Voyager Therapeutics (VYGR) Profit After Tax (QoQ) (2014 - 2026)
Voyager Therapeutics (VYGR) Profit After Tax (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Voyager Therapeutics | 184.74 Mn | 43.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.91% |
| Dec 31, 2025 | -11,936.40% |
| Sep 30, 2025 | 100.68% |
| Jun 30, 2025 | -16,149.04% |
| Mar 31, 2025 | 155.61% |
| Dec 31, 2024 | 95.63% |
| Sep 30, 2024 | 15.64% |
| Jun 30, 2024 | 10.49% |
| Mar 31, 2024 | -108.55% |
| Dec 31, 2023 | 609.42% |
| Sep 30, 2023 | -17.15% |
| Jun 30, 2023 | -117.90% |
| Mar 31, 2023 | 623.24% |
| Dec 31, 2022 | -234.31% |
| Sep 30, 2022 | 192.48% |
| Jun 30, 2022 | 10.47% |
| Mar 31, 2022 | -127.72% |
| Dec 31, 2021 | 405.88% |
| Sep 30, 2021 | 16.54% |
| Jun 30, 2021 | -39.13% |